Clinical Trial Application Submission Guidance

Clinical Trial Application Submission Guidance Purpose: The purpose of this guidance document is to outline DAIDS’ requirements regarding the submission of Clinical Trials Applications (CTAs) to DAIDS to ensure compliance with ICH E6. This document

Tags:

  Applications, Guidance, Clinical, Trail, Submissions, Clinical trial application submission guidance

Information

Documents from same domain

Grading Adverse Events - National Institutes of Health

rsc.niaid.nih.gov

Alanine aminotransferase (serum glutamic pyruvic transaminase) ANC . Absolute neutrophil count . AST (SGOT) Aspartate aminotransferase (serum glutamic-oxaloacetic transaminase) AV . Atrioventricular . Basic Self-care Functions . Adult Activities such as bathing, dressing, toileting, transfer or movement,

  Adverse, Alanine, Glutamic, Transaminase, Aminotransferase, Glutamic pyruvic transaminase, Pyruvic, Alanine aminotransferase

Division of AIDS (DAIDS) Table for Grading the Severity of ...

rsc.niaid.nih.gov

Grading Adult and Pediatric AEs When a single parameter is not appropriate for grading an AE in both adult and pediatric populations, separate parameters with specified age ranges are provided. If no distinction between adult and pediatric populations has been made, the listed parameter should be used for grading an AE in both populations.

  Grading, Addis

DEPO-PROVERA- medroxyprogesterone acetate injection ...

rsc.niaid.nih.gov

14.3 Bone Mineral Density Changes in Adolescent Females (12–18 years of age) ... continuous contraceptive coverage based upon the mechanism of action of both methods, (e.g., patients switching ... anorexia nervosa, strong family history of osteoporosis or chronic use of drugs that can reduce bone mass such as anticonvulsants or corticosteroids).

  Based, Family, Adolescent, Anorexia, Depo, Depo provera, Provera, Anorexia nervosa, Nervosa

Related documents

CPMP NOTE FOR GUIDANCE ON THE CLINICAL …

www.ema.europa.eu

Note for Guidance [EMEA status as of November 1995] This guideline should be read in conjunction with Directive 65/65 /EEC as amended, the Note for Guidance on abridged application (III/3879/90), the Notice to Applicants for the new system and, where relevant, the Note for Guidance on non-clinical local tolerance testing of medicinal products.

  Applications, Guidance, Clinical

External Guidance on the implementation of Policy 0070

www.ema.europa.eu

External guidance on the procedural aspects related to the submission of clinical reports for the purpose of publication in accordance with EMA Policy 0070 (see Chapter 2). External guidance on the anonymisation of clinical reports for the purpose of publication in accordance with EMA Policy 0070 (see Chapter 3).

  Implementation, Guidance, Clinical, Submissions, External, External guidance on the implementation

Essential Regulatory Documents Guidance and Binder Tabs

files.nccih.nih.gov

Jul 17, 2015 · Guidance and Binder Tabs ... • It is the responsibility of the investigator to ensure compliance with good clinical practice (GCP), institutional review board (IRB), and applicable regulatory requirements. ... included on each document included in the submission.

  Guidance, Clinical, Submissions

Related search queries